Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Progress in gene therapy for neurological disorders.

Simonato M, Bennett J, Boulis NM, Castro MG, Fink DJ, Goins WF, Gray SJ, Lowenstein PR, Vandenberghe LH, Wilson TJ, Wolfe JH, Glorioso JC.

Nat Rev Neurol. 2013 May;9(5):277-91. doi: 10.1038/nrneurol.2013.56. Epub 2013 Apr 23. Review. Erratum in: Nat Rev Neurol. 2013 Jun;9(6):298.

2.

Gene therapy for neurological disorders.

Choong CJ, Baba K, Mochizuki H.

Expert Opin Biol Ther. 2016;16(2):143-59. doi: 10.1517/14712598.2016.1114096. Epub 2015 Dec 5. Review.

PMID:
26642082
3.

Large animal models of neurological disorders for gene therapy.

Gagliardi C, Bunnell BA.

ILAR J. 2009;50(2):128-43. Review.

4.

Recent advances in the pharmacology of neurological gene therapy.

Lowenstein PR, Castro MG.

Curr Opin Pharmacol. 2004 Feb;4(1):91-7. Review.

5.

Channelrhodopsins-Their potential in gene therapy for neurological disorders.

Ji ZG, Ishizuka T, Yawo H.

Neurosci Res. 2013 Jan;75(1):6-12. doi: 10.1016/j.neures.2012.09.004. Epub 2012 Sep 28. Review.

PMID:
23026479
6.

Gene therapy for diseases of the nervous system.

Fick J, Israel MA.

West J Med. 1994 Sep;161(3):260-3. Review.

7.

Gene therapy for psychiatric disorders.

Sapolsky RM.

Am J Psychiatry. 2003 Feb;160(2):208-20. Review.

PMID:
12562564
8.

Recent gene therapy advancements for neurological diseases.

Nagabhushan Kalburgi S, Khan NN, Gray SJ.

Discov Med. 2013 Feb;15(81):111-9. Review.

9.

[Gene therapy in neurological diseases].

Głabiński AR.

Neurol Neurochir Pol. 2001 Nov-Dec;35(6):1111-9. Review. Polish.

PMID:
11987706
10.

Gene therapy for childhood neurological disease.

Sahin M.

Pediatr Neurol. 2014 Nov;51(5):595-6. doi: 10.1016/j.pediatrneurol.2014.08.005. Epub 2014 Aug 15. No abstract available.

PMID:
25439574
11.

Regulated protein expression for in vivo gene therapy for neurological disorders: progress, strategies, and issues.

Manfredsson FP, Bloom DC, Mandel RJ.

Neurobiol Dis. 2012 Nov;48(2):212-21. doi: 10.1016/j.nbd.2012.03.001. Epub 2012 Mar 9. Review.

PMID:
22426391
12.

Human gene therapy and imaging in neurological diseases.

Jacobs AH, Winkler A, Castro MG, Lowenstein P.

Eur J Nucl Med Mol Imaging. 2005 Dec;32 Suppl 2:S358-83. Review. Erratum in: Eur J Nucl Med Mol Imaging. 2006 Mar;33(3):390.

13.

Applications of lentiviral vectors for biology and gene therapy of neurological disorders.

Lundberg C, Björklund T, Carlsson T, Jakobsson J, Hantraye P, Déglon N, Kirik D.

Curr Gene Ther. 2008 Dec;8(6):461-73. Review.

PMID:
19075629
14.

Neurological gene therapy.

Fooks AR, Jennings AD, Doyle A, Clegg JC, Stacey GN.

Sci Prog. 1997;80 ( Pt 2):107-24. Review. No abstract available.

PMID:
9263509
15.

Healing genes in the nervous system.

Breakefield XO, Sena-Esteves M.

Neuron. 2010 Oct 21;68(2):178-81. doi: 10.1016/j.neuron.2010.10.005.

16.

Applied neurogenomics.

Jain KK.

Pharmacogenomics. 2001 May;2(2):143-52. Review.

PMID:
11368753
17.

Development of nucleic acid drugs for neurological disorders.

Shimamura M, Sato N, Nakagami H, Taniyama Y, Morishita R.

Curr Top Med Chem. 2012;12(15):1621-9. Review.

PMID:
22762559
18.

Targeting the neurovascular unit for treatment of neurological disorders.

Vangilder RL, Rosen CL, Barr TL, Huber JD.

Pharmacol Ther. 2011 Jun;130(3):239-47. doi: 10.1016/j.pharmthera.2010.12.004. Epub 2010 Dec 21. Review.

19.
20.

Stem cell-based cell therapy in neurological diseases: a review.

Kim SU, de Vellis J.

J Neurosci Res. 2009 Aug 1;87(10):2183-200. doi: 10.1002/jnr.22054. Review.

PMID:
19301431

Supplemental Content

Support Center